Concepedia

Josu Iraola‐Truchuelo

JI

5

Publications

129

Citations

5

H-Index

2022

Active since

Affiliations

Vall d'Hebron Hospital Universitari(Current)

Vall d'Hebron Institute of Oncology

Hospital General Universitario Gregorio Marañón

Vall d'Hebron Institut de Recerca

Hospital Clínic de Barcelona

Josu Iraola‐Truchuelo is an author at Vall d'Hebron Hospital Universitari specializing in cellular therapies, radiation oncology, and autoimmunity.

ORCID

Top concepts

Publications per year

2022–2024

5

Publications

5

Efficacy of CAR T-cell therapy is not impaired by previous bispecific antibody treatment in large B-cell lymphoma

Gilles Crochet, Gloria Iacoboni, Audrey Couturier et al. · Blood · 2024 · 49 citations · Full text

Treatment outcomes in patients with large B‐cell lymphoma after progression to chimeric antigen receptor T‐cell therapy

Gloria Iacoboni, Josu Iraola‐Truchuelo, Maeve O’Reilly et al. · HemaSphere · 2024 · 31 citations · Full text

Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL

Viktoria Blumenberg, Galina Busch, S. Baumann et al. · Blood Advances · 2023 · 22 citations · Full text

Salvage Treatment with Novel Agents Is Preferable to Standard Chemotherapy in Patients with Large B-Cell Lymphoma Progressing after Chimeric Antigen Receptor T-Cell Therapy

Gloria Iacoboni, Josu Iraola‐Truchuelo, Alberto Mussetti et al. · Blood · 2022 · 14 citations

, , +12

PET‐based radiomics signature can predict durable responses to CAR T‐cell therapy in patients with large B‐cell lymphoma

Marta Ligero, Marc Simó, Cecilia Carpio et al. · eJHaem · 2023 · 13 citations · Full text

Rows per page

1–5 of 5